We recently posted that Covance was planning on opening up several offices across Eastern Europe, and now according to this article in novinite.com PPD is set to buy AbCRO, which is Bulgarian based CRO, in order to expand its drug testing businesses in Eastern and Central Europe.
The purchase which is expected to be completed in March will add Romania, Bulgaria, Serbia and Croatia to PPD’s operations in Europe and also help bolster its already existing operations in Poland, Russia and the Ukraine. What other clinical trials companies are investing heavily in Eastern and Central Europe?
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
February
(16)
- February Edition of Partnerships with CROs LinkedI...
- Unethical Clinical Trial Outsourcing
- New regulations from the Indian government
- Raising alarms, study sees trials migrating abroad
- Is Outsourcing of Clinical Trials Faulty?
- How to rescue a clinical trial
- Pfizer Plans to Disclose Payments Made to Clinical...
- Quintiles opens up Phase I Unit in India
- Microdosing could be a win/win for pharma, CROs
- PPD Extends its Reach to Eastern and Central Europe
- NIH Awards University of Texas $1.8M in Research G...
- Covance Opens Offices in Ukraine, Slovakia and Israel
- Covance expands into Eastern Europe and Middle East
- India to Conduct 5% Global Clinical Trials by 2012
- Executives are on the Move in the Outsourcing Indu...
- PRA International expands into southwest Asia
-
▼
February
(16)
No comments:
Post a Comment